FI970714A - Menetelmä luuproteesin rappeutumisen estämiseksi - Google Patents

Menetelmä luuproteesin rappeutumisen estämiseksi Download PDF

Info

Publication number
FI970714A
FI970714A FI970714A FI970714A FI970714A FI 970714 A FI970714 A FI 970714A FI 970714 A FI970714 A FI 970714A FI 970714 A FI970714 A FI 970714A FI 970714 A FI970714 A FI 970714A
Authority
FI
Finland
Prior art keywords
procedure
bone protein
preventing degeneration
degeneration
preventing
Prior art date
Application number
FI970714A
Other languages
English (en)
Swedish (sv)
Other versions
FI970714A0 (fi
Inventor
George Joseph Cullinan
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of FI970714A publication Critical patent/FI970714A/fi
Publication of FI970714A0 publication Critical patent/FI970714A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
FI970714A 1994-08-22 1997-02-20 Menetelmä luuproteesin rappeutumisen estämiseksi FI970714A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/294,170 US5550123A (en) 1994-08-22 1994-08-22 Methods for inhibiting bone prosthesis degeneration
PCT/US1995/010616 WO1996005824A1 (en) 1994-08-22 1995-08-21 Methods for inhibiting bone prosthesis degeneration

Publications (2)

Publication Number Publication Date
FI970714A true FI970714A (fi) 1997-02-20
FI970714A0 FI970714A0 (fi) 1997-02-20

Family

ID=23132213

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970714A FI970714A0 (fi) 1994-08-22 1997-02-20 Menetelmä luuproteesin rappeutumisen estämiseksi

Country Status (18)

Country Link
US (1) US5550123A (fi)
EP (1) EP0769944A4 (fi)
JP (1) JPH10504576A (fi)
KR (1) KR970705384A (fi)
CN (1) CN1076968C (fi)
AU (1) AU701789B2 (fi)
CA (1) CA2198118A1 (fi)
CZ (1) CZ52097A3 (fi)
FI (1) FI970714A0 (fi)
HU (1) HUT76825A (fi)
IL (1) IL115021A (fi)
MX (1) MX9701334A (fi)
MY (1) MY132085A (fi)
NO (1) NO970786L (fi)
NZ (1) NZ292013A (fi)
UA (1) UA26204C2 (fi)
WO (1) WO1996005824A1 (fi)
ZA (1) ZA956990B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856340A (en) 1995-02-28 1999-01-05 Eli Lilly And Company Method of treating estrogen dependent cancers
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
HUP0200871A3 (en) 1999-05-04 2004-04-28 Strakan Int Ltd Androgen glycosides and androgenic activity thereof
AU2001271784A1 (en) * 2000-07-06 2002-01-21 Wyeth Therapy for prosthesis-related bone degeneration
US9101978B2 (en) 2002-12-08 2015-08-11 Baker Hughes Incorporated Nanomatrix powder metal compact
US9079246B2 (en) 2009-12-08 2015-07-14 Baker Hughes Incorporated Method of making a nanomatrix powder metal compact
US8403037B2 (en) 2009-12-08 2013-03-26 Baker Hughes Incorporated Dissolvable tool and method
US9227243B2 (en) 2009-12-08 2016-01-05 Baker Hughes Incorporated Method of making a powder metal compact
US8776884B2 (en) 2010-08-09 2014-07-15 Baker Hughes Incorporated Formation treatment system and method
US9139928B2 (en) 2011-06-17 2015-09-22 Baker Hughes Incorporated Corrodible downhole article and method of removing the article from downhole environment
US9057242B2 (en) 2011-08-05 2015-06-16 Baker Hughes Incorporated Method of controlling corrosion rate in downhole article, and downhole article having controlled corrosion rate
US9033055B2 (en) 2011-08-17 2015-05-19 Baker Hughes Incorporated Selectively degradable passage restriction and method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US441868A (en) * 1890-12-02 Mechanical power
US4133814A (en) * 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) * 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) * 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5075321A (en) * 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
DE4122484A1 (de) * 1991-07-06 1993-01-07 Teves Gmbh Alfred Schaltungsanordnung zur erkennung von radsensordefekten
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5441964A (en) * 1993-10-15 1995-08-15 Eli Lilly And Company Methods for inhibiting bone loss using substituted benzothiophene

Also Published As

Publication number Publication date
MY132085A (en) 2007-09-28
EP0769944A1 (en) 1997-05-02
AU701789B2 (en) 1999-02-04
KR970705384A (ko) 1997-10-09
ZA956990B (en) 1997-02-21
WO1996005824A1 (en) 1996-02-29
US5550123A (en) 1996-08-27
FI970714A0 (fi) 1997-02-20
CZ52097A3 (en) 1997-08-13
NO970786D0 (no) 1997-02-20
MX9701334A (es) 1997-05-31
EP0769944A4 (en) 1998-12-30
CA2198118A1 (en) 1996-02-29
AU3369595A (en) 1996-03-14
IL115021A0 (en) 1995-12-08
CN1076968C (zh) 2002-01-02
NZ292013A (en) 2000-07-28
JPH10504576A (ja) 1998-05-06
IL115021A (en) 2000-06-29
NO970786L (no) 1997-02-20
UA26204C2 (uk) 1999-07-19
CN1156406A (zh) 1997-08-06
HUT76825A (en) 1997-11-28

Similar Documents

Publication Publication Date Title
FI974432A0 (fi) Grampositiivisten bakteerien käyttö rekombinanttiproteiinien ilmentämiseksi
DE69837264D1 (de) Dipeptidderivate zur förderung der sekretion von wachstumshormon
NO986202D0 (no) FremgangsmÕte for fremstilling av rekombinant adÚnovirus
FI953649A0 (fi) Biomagnetometri, jolla aikaansaadaan koko pään peitto istuvasta tai makuulla olevasta kohteesta
DE69629568D1 (de) Reinigungs-und desinfektionsverfahren für essbare tierische proteine
FI972657A0 (fi) Proteiinien ja peptidien aerosoliformuloinnit
NO994757L (no) Fremgangsmåte for oral administrasjon av proteiner
DE1009484T1 (de) Verfahren zur korneallaserchirurgie
NO995134L (no) Forbedrede fremgangsmåter for fremstilling av aktivert protein C
FI973244A0 (fi) Farmaseuttisia valmisteita nenänsisäiseen käyttöönFarmaseuttisia valmisteita nenänsisäiseen käyttöön
FI970714A (fi) Menetelmä luuproteesin rappeutumisen estämiseksi
ATE273031T1 (de) Aminobiguanide und ihre verwendung zur desinfektion von kontaktlinsen und konservierung von pharmazeutischen zubereitungen
FI963813A0 (fi) Menetelmä vierteen keittämiseksi jatkuvasti
FI970973A (fi) Bensiinin laatua parantava menetelmä
FI954632A0 (fi) Korrigering av stoetbreddning hos icke-dispersiv absorptionsmaetning av gasar
DE69838667D1 (de) Verfahren zur stabilisierung nützlicher proteine und nützliche proteinhaltige mittel
FI940316A (fi) Menetelmä heraproteiinien fraktioimiseksi
FI953709A (fi) Menetelmä hiusten kasvun edistämiseksi
AU2205499A (en) Human regulatory proteins
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
AU7954298A (en) Human protein phosphatase ii-c-like protein
FI953170A0 (fi) Oligunokleotidit isoprenyyliproteiinitransferaasin ilmentämisen inhibiboimiseksi
FI940846A0 (fi) Menetelmä heraproteiinien eristämiseksi
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
FI963947A0 (fi) Täydellisesti liuennut luukudos ja menetelmä sen valmistamiseksi